Methods of treating hematological proliferative disorders by targeting EphA3 expressed on aberrant vasculature in bone marrow
- 专利权人:
- Inc.;KaloBios Pharmaceuticals
- 发明人:
- Yarranton, Geoffrey T.,Palath, Varghese,Bebbington, Christopher R.,Baer, Mark
- 申请号:
- AU2012295334
- 公开号:
- AU2012295334A1
- 申请日:
- 2012.08.10
- 申请国别(地区):
- AU
- 年份:
- 2013
- 代理人:
- 摘要:
- The invention provides diagnostic and therapeutic methods for the treatment of hematological proliferative disorders.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- METHODS OF TREATING HEMATOLOGICAL PROLIFERATIVE DISORDERS BY TARGETING EPHA3 EXPRESSED ON ABERRANT VASCULATURE IN BONE MARROW
- METHODS OF TREATING HEMATOLOGICAL PROLIFERATIVE DISORDERS BY TARGETING EPHA3 EXPRESSED ON ABERRANT VASCULATURE IN BONE MARROW
- Method for treating blood proliferative diseases by targeting EphA3 expressed on abnormal vasculature in bone marrow
- METHODS OF TREATING HEMATOLOGICAL PROLIFERATIVE DISORDERS BY TARGETING EPHA3 EXPRESSED ON ABERRANT VASCULATURE IN BONE MARROW
- MÉTHODES DE TRAITEMENT DE TROUBLES PROLIFÉRATIFS HÉMATOLOGIQUES CONSISTANT À DIRIGER L'EPHA3 EXPRIMÉ SUR UNE VASCULATURE ABERRANTE DANS LA MOELLE OSSEUSE